“…EGFR is activated upon binding to its ligands, such as epidermal growth factor (EGF) and TGF-a (Pawson, 1995;Schlessinger and Ullrich, 1992). There is no known ligand for ErbB2, but its activation is believed to be due to its overexpression (Akiyama et al, 1986;DiGiovanna and Stern, 1995). Upon activation, either by ligand binding or protein overexpression, dimerization and stabilization of RTKs occur, resulting in stimulation of tyrosine kinase activities and autophosphorylation on tyrosine residues (Downward et al, 1984;Hazan et al, 1989;Margolis et al, 1989).…”